December 06, 2017
ATCC and ABRF Tap Extreme Environments to Move Microbiome Analyses Towards Standardization
ATCC and the Association of Biomolecular Resource Facilities Metagenomics Research Group (ABRF-MGRG) announce the launch of three new microbiome reference standards comprising genomic DNA prepared from microorganisms prevalent in extreme environments.
November 27, 2017
ATCC Develops Novel in Vitro Model to Investigate Drug Candidates for Cancer Metastasis
ATCC announces the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer.
October 16, 2017
ATCC to Present at Upcoming Association of Molecular Pathology Conference
During Association of Molecular Pathology (AMP) conference subject matter experts from ATCC emphasize the importance and need for consistent, reliable standards for next-generation sequencing.
September 28, 2017
ATCC Announces New Appointments to its Leadership Team
ATCC announces two appointments to the senior leadership team. Mr. Daniel Kelly joins ATCC as Chief Information and Technology Officer (CITO), and Mr. John Sweeney joins as Chief Financial Officer (CFO).
August 08, 2017
ATCC Answers World Health Organization’s Call to Arms in the Race Against Antimicrobial Resistance
ATCC, in partnership with the Institute for Life Science Entrepreneurship (ILSE) and the ATCC Center for Translational Microbiology (ATCC-CTM), announces the launch of the ATCC Global Priority Superbugs collection.
May 31, 2017
ATCC and One Codex Form Collaboration to Address Challenges of Microbiome Research
ATCC and One Codex announce the formation of a partnership to address microbiome research needs.
May 08, 2017
ATCC and The Michael J. Fox Foundation for Parkinson's Research to Facilitate Workshop
Subject matter experts from ATCC partner with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to facilitate a corporate workshop at the International Society for Biological and Environmental Repositories (ISBER) 2017 Annual Meeting.
April 21, 2017
ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD
ATCC's new cGMP-compliant biorepository is dedicated to the storage, distribution, and management of cell lines and other biomaterials for a wide variety of customers including vaccine, biotechnology and pharmaceutical companies, clinical laboratories, academic institutions, foundations, and federal agencies.
March 14, 2017
NCI Selects ATCC to Provide End-to-End Cancer Epidemiology Services
The National Cancer Institute (NCI) awards ATCC a five-year indefinite-delivery/indefinite-quantity (IDIQ) contract to support the Division of Cancer Epidemiology and Genetics’ (DCEG) Molecular Epidemiology Assay Support (MEAS) program.
